Related Experiment Video
Updated: Jan 26, 2026

Liver Cold Storage and Transplantation in the Cold-Adaptive Daurian Ground Squirrels
Published on: July 3, 2025
The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients
Mohammad Bilal Siddiqui1, Samarth Patel1, Tamoore Arshad2
1Division of Gastroenterology and Hepatology, Virginia Commonwealth University, Richmond, VA.
Insights
Low adiponectin (hypoadiponectinemia) significantly predicts cardiovascular disease (CVD) events after liver transplantation (LT). This finding is independent of other risk factors, aiding future CVD risk assessment in LT recipients.
Area of Science:
- Cardiology
- Hepatology
- Endocrinology
Background:
- Cardiovascular disease (CVD) is a major cause of death post-liver transplantation (LT).
- Serum adiponectin levels are linked to CVD outcomes, but its role in hypoadiponectinemia after LT is unclear.
Purpose of the Study:
- To prospectively investigate the association between low serum adiponectin levels and the risk of CVD events in liver transplant recipients (LTR).
Main Methods:
- 130 liver transplant recipients were enrolled and followed for CVD events.
- Hypoadiponectinemia was defined as serum adiponectin <10 µg/mL.
- A composite CVD outcome included myocardial infarction, angina, revascularization, stroke, or cardiac death.
Main Results:
- A total of 20 CVD events occurred during a median follow-up of 45 months.
- Hypoadiponectinemia was significantly associated with an increased risk of CVD events (HR, 3.519; P=0.024).
- This association remained significant and independent of traditional CVD risk factors and immunosuppression.
Conclusions:
- Low serum adiponectin is a strong, independent predictor of future cardiovascular events in liver transplant recipients.
- Incorporating adiponectin levels into clinical practice can improve CVD risk assessment post-LT.
Background:
Cardiovascular disease (CVD) is an important cause of morbidity and mortality after liver transplantation (LT). Serum adiponectin levels inversely correlate with CVD-related outcomes, but the relationship between hypoadiponectinemia and CVD after LT is unknown. Thus, the aim of the present study was to prospectively evaluate this relationship in LT recipients (LTR).
Methods:
LTR were prospectively enrolled (N = 130) between January 1, 2012, and January 1, 2014. Baseline adiponectin levels were drawn at enrollment and patients were followed for CVD events. Hypoadiponectinemia was defined as serum adiponectin <10 µg/mL. The primary endpoint was a composite CVD outcome consisting of myocardial infarction, angina, need for coronary revascularization, stroke, or cardiac death.
Results:
The mean age was 58 ± 11 years and prevalence of obesity, diabetes, and dyslipidemia was 40%, 35%, and 40%, respectively. A total of 20 CVD events were noted, after median follow up of 45 months. Hypoadiponectinemia was significantly associated with future risk of CVD events (hazard ratio, 3.519; 95% confidence interval, 1.180-10.499, P = 0.024). This association was independent of traditional CVD risk factors including age, gender, obesity, hypertension, diabetes, and choice of immunosuppression.
Conclusions:
Hypoadiponectinemia is a strong independent predictor of future cardiovascular events in LTR, which can be incorporated in clinical practice to assess CVD risk assessment after LT.
Related Concept Videos
Relationship Formation
Ending Relationships
Relationship Growth
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Social Relationships and Well-Being
Integration of Synaptic Events

